首页> 外国专利> Pharmacological components of oral management include (a) a mixture of 1-35 p/p of Fexofenodina and (b) a mixture of at least 60 p/p dissolving at least one non-ionic surface active substance and at least one non-ionic hydrogen FOBIC surface active substance; its preparation method; and its use in tra. Allergy test.

Pharmacological components of oral management include (a) a mixture of 1-35 p/p of Fexofenodina and (b) a mixture of at least 60 p/p dissolving at least one non-ionic surface active substance and at least one non-ionic hydrogen FOBIC surface active substance; its preparation method; and its use in tra. Allergy test.

机译:口服治疗的药理成分包括(a)1-3%p / p的Fexofenodina混合物和(b)至少60%p / p的混合物,以溶解至少一种非离子表面活性物质和至少一种非离子表面活性物质离子氢FOBIC表面活性物质;其制备方法;及其在tra中的使用过敏测试。

摘要

Pharmaceutical composition for oral administration comprising) 1 to 35% w / W of Fexofenadine hydrochloride and (b) at least 60% w / W of a Liquid mixture of at least a Hydrophilic nonionic Surfactant and at least a Hydrophobic nonionic Surfactant, its preparation method and its use for the tra; Treatment of allergic reactions.
机译:用于口服的药物组合物,其包含:1至35%w / W的盐酸非索非那定和(b)至少60%w / W的至少一种亲水性非离子表面活性剂和至少一种疏水性非离子表面活性剂的液体混合物,制备方法及其在tra中的用途;过敏反应的治疗。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号